ST
FOLD

Spot Trading’s Amicus Therapeutics FOLD Stock Holding History

Spot Trading’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$362K Sell
24,000
-3,600
-13% -$47.6K 0.01% 1859
2017
Q2 		$278K Sell
27,600
-12,900
-32% -$104K 0.01% 2005
2017
Q1 		$289K Buy
40,500
+26,000
+179% +$164K 0.01% 1659
2016
Q4 		$72K Sell
14,500
-10,500
-42% -$72.7K ﹤0.01% 2320
2016
Q3 		$185K Buy
+25,000
New +$169K ﹤0.01% 2134
2015
Q4 		– Sell
-32,800
Closed -$459K – 3758
2015
Q3 		$459K Buy
32,800
+11,200
+52% +$176K ﹤0.01% 2112
2015
Q2 		$306K Buy
21,600
+12,700
+143% +$153K ﹤0.01% 2428
2015
Q1 		$97K Buy
+8,900
New +$78.5K ﹤0.01% 3083
2014
Q4 		– Sell
-3,200
Closed -$19K – 4137
2014
Q3 		$19K Buy
+3,200
New +$16.8K ﹤0.01% 3961

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Spot Trading's FOLD Position: Q3 2017 in Review

Spot Trading increased its Amicus Therapeutics (FOLD) stake by 57% in Q3 2017, buying an estimated $75.2K and bringing the position to 15,578 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #2135.

Spot Trading first reported a position in FOLD in Q3 2014 and has held it in 8 quarters since. 186 funds tracked by Wall St. Rank hold FOLD as of Q3 2017.

  • Spot Trading held 15,578 shares of Amicus Therapeutics worth $235K as of Q3 2017.
  • Spot Trading bought 5,686 Amicus Therapeutics shares in Q3 2017, an estimated $75.2K.
  • Amicus Therapeutics made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2135 holding.
  • Spot Trading first reported a position in Amicus Therapeutics in Q3 2014 and has held it in 8 quarters since.
  • 186 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.